- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Aviza Technology, Inc. (NASDAQ:AVZA), a supplier of advanced semiconductor equipment and process technologies for the global semiconductor, compound semiconductor, nanotechnology and other related markets, announced today that it will be participating in the Thomas Weisel Partners Tech2007 Conference. Aviza's management team is scheduled to present Wednesday, February 7, 2007 at The Fairmont Hotel in San Francisco, CA at 2:40 p.m. Pacific Standard Time.
About Aviza Technology
Aviza Technology, Inc. is a supplier of advanced semiconductor equipment and process technologies for the global semiconductor, compound semiconductor, nanotechnology and other related markets. Aviza offers both front-end-of-line (FEOL) and back-end-of-line (BEOL) process applications including products for atomic layer deposition (ALD), diffusion and low pressure chemical vapor deposition (LPCVD) furnaces, atmospheric pressure CVD (APCVD), CVD, etch and physical vapor deposition (PVD). The company is publicly traded on the NASDAQ Global Market (NASDAQ GM:AVZA). Aviza is headquartered in Scotts Valley, Calif., with manufacturing, R&D, sales and customer support facilities located in the UK, Germany, France, Italy, Taiwan, China, Japan, Korea, Singapore and Malaysia. Additional information about the company can be found at http://www.avizatechnology.com .
For more information, please click here
Aviza Technology, Inc.
Sherrie Gutierrez, +1 831-439-6382
Fax: +1 831-439-6223
Corporate Marketing Manager
Laura Guerrant, Principal, +1 808-882-1467
Fax: +1 808-882-1267
Copyright © Business WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
The quantum middle man July 2nd, 2015
Emergence of a 'devil's staircase' in a spin-valve system July 1st, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015